We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.66%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$70B
AUM Growth
+$9.17B
(+15%)
Cap. Flow
+$1.72B
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
24.19%
Holding
1,743
New
270
Increased
557
Reduced
362
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$575M |
| 2 |
Johnson & Johnson
JNJ
|
+$414M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$331M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$241M |
| 5 |
Microsoft
MSFT
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$470M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$278M |
| 3 |
Eaton
ETN
|
+$269M |
| 4 |
PLDT
PHI
|
+$195M |
| 5 |
AB InBev
BUD
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.33% |
| 2 | Healthcare | 15.85% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 13.3% |
| 5 | Communication Services | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Columbus McKinnon
CMCO
$553M
| $28.1M | 0.04% |
703,206
+147,408
| +27% | +$5.7M |
|
|
PEO
252
Adams Natural Resources Fund
PEO
$739M
| $28.1M | 0.04% |
1,772,812
-19,646
| -1% | -$300K |
|
253
Burlington
BURL
$23.2B
| $28M | 0.04% |
122,822
+28,844
| +31% | +$6.03M |
|
|
TCF
254
DELISTED
TCF Financial Corporation Common Stock
TCF
| $28M | 0.04% |
597,590
+591,053
| +9,042% | +$24.5M |
|
255
Adobe
ADBE
$99.5B
| $27.9M | 0.04% |
84,594
+6,454
| +8% | +$1.9M |
|
|
CTLT
256
DELISTED
CATALENT, INC.
CTLT
| $27.7M | 0.04% |
491,149
+34,119
| +7% | +$1.74M |
|
|
RP
257
DELISTED
RealPage, Inc.
RP
| $27.6M | 0.04% |
513,169
+25,759
| +5% | +$1.47M |
|
258
Charles River Laboratories
CRL
$11.2B
| $27.5M | 0.04% |
180,329
+44,303
| +33% | +$6.13M |
|
|
CERN
259
DELISTED
Cerner Corp
CERN
| $27.5M | 0.04% |
374,584
+8,148
| +2% | +$563K |
|
260
Edwards Lifesciences
EW
$49.6B
| $27.2M | 0.04% |
350,079
+275,847
| +372% | +$21.5M |
|
261
Brink's
BCO
$4.88B
| $26.9M | 0.04% |
297,130
+9,189
| +3% | +$811K |
|
|
AZUL
262
DELISTED
Azul
AZUL
| $26.6M | 0.04% |
621,023
+18,589
| +3% | +$716K |
|
263
Vanguard FTSE Europe ETF
VGK
$30.7B
| $26.6M | 0.04% |
453,547
+125,165
| +38% | +$7M |
|
264
LCI Industries
LCII
$2.49B
| $26.2M | 0.04% |
244,613
+8,607
| +4% | +$871K |
|
265
Encompass Health
EHC
$11B
| $26.2M | 0.04% |
474,887
+43,838
| +10% | +$2.38M |
|
266
Camden Property Trust
CPT
$11B
| $26M | 0.04% |
244,791
+19,706
| +9% | +$2.18M |
|
267
Ciena
CIEN
$53.4B
| $25.9M | 0.04% |
606,985
+102,639
| +20% | +$3.91M |
|
268
American Electric Power
AEP
$69.6B
| $25.9M | 0.04% |
274,102
-995
| -0.4% | -$91.9K |
|
269
Cummins
CMI
$87.5B
| $25.9M | 0.04% |
144,706
+774
| +0.5% | +$136K |
|
270
Itaú Unibanco
ITUB
$93.2B
| $25.8M | 0.04% |
3,872,035
+540,268
| +16% | +$3.38M |
|
271
Walmart Inc
WMT
$885B
| $25.8M | 0.04% |
650,445
+153,468
| +31% | +$6.09M |
|
272
Truist Financial
TFC
$63.3B
| $25.2M | 0.04% |
446,597
+15,603
| +4% | +$845K |
|
273
Icon
ICLR
$12.6B
| $24.9M | 0.04% |
144,523
+42,775
| +42% | +$6.6M |
|
274
Campbell Soup
CPB
$6.55B
| $24.6M | 0.04% |
498,141
+134,000
| +37% | +$6.35M |
|
275
Americold
COLD
$4.02B
| $24.5M | 0.04% |
698,390
-121,884
| -15% | -$4.48M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Lazard Asset Management held 1,743 positions worth $70B, up 15% from $60.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management's Q4 2019 filing shows 270 new, 557 increased, 362 reduced and 215 closed positions. Its largest new stake was West Pharmaceutical: 89,164 shares worth $13.4M. The largest sale was NetEase, an estimated $470M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Lazard Asset Management's largest Q4 2019 buy was West Pharmaceutical: 89,164 shares worth $13.4M.
- Lazard Asset Management added most to McDonald's in Q4 2019, an estimated $575M increase.
- Lazard Asset Management's biggest Q4 2019 reduction was NetEase, cutting an estimated $470M.
- Lazard Asset Management fully exited Corelogic, Inc. in Q4 2019, selling an estimated $68.4M.
- Lazard Asset Management's ten largest holdings make up 24% of its $70B portfolio in Q4 2019.
- Lazard Asset Management opened 270 new positions and closed 215 in Q4 2019.
- Lazard Asset Management's portfolio value rose 15% quarter-over-quarter to $70B.
Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.